Lundbeck announces availability of new therapy for rare neurologic disorder
Tuesday, September 2, 2014
WPC Scientific Update Lead Supporter Lundbeck Announces Availability of NORTHERA™ (droxidopa) Capsules in the U.S. for Symptomatic Neurogenic Orthostatic Hypotension (NOH).
NOH is a Disorder Caused by an Underlying Neurologic Disease (e.g., Parkinson's Disease, Multiple System Atrophy or Pure Autonomic Failure)
Read more: http://bit.ly/1tqDLDR